Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 350
- 试验地点
- 2
- 主要终点
- Assessment of OX40L expression in endothelial cells and skin biopsies.
研究概览
简要总结
It is a study of basic research with mechanistically objectives and including clinical biological samples.
详细描述
Systemic sclerosis (SSc) is a rare and severe disease characterised by a fibrotic process and an incompletely elucidate physiopathology. Several shared featured have been identified between SSc and another autoimmune disease, the systemic lupus erythematous (SLE) as an interferon-alpha signature, the role of platelets and the polymorphism of OX40 ligand (OX40L). In SLE, OX40L has been shown highly linked to the active form of the disease, was increased by the CD40L of platelets and induced the CD8 cytotoxicity while inhibiting the suppressive functions of regulator T lymphocytes. The third main factor of the SSc physiopathology apart from autoimmunity and fibrosis is the vasculopathy with an important role of endothelial cells (EC). They turned out to be half-professional antigen presenting cells and can modulate the adaptive immunity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age from 18 to
- •SSc diagnosed according to the American College of Rheumatology (ACR) criteria.
- •With skin manifestations since less than 10 years.
- •Localised sclerosis (LSc) diagnosed, morphea type.
排除标准
- •Age inferior to 18 or upper than
- •Skin manifestations since more than 10 years.
- •Haemostasis diseases (independent from treatments).
- •Stem cell transplant.
- •Immunosuppressive treatments in the last 6 months.
- •Associate autoimmune disease.
研究组 & 干预措施
subjects Sc
干预措施: Blood samples (Biological)
subjects SSc diagnosed
干预措施: Blood samples (Biological)
subjects SSc diagnosed
干预措施: Biopsy (Biological)
subjects Localised sclerosis diagnosed
干预措施: Blood samples (Biological)
subjects Localised sclerosis diagnosed
干预措施: Biopsy (Biological)
结局指标
主要结局
Assessment of OX40L expression in endothelial cells and skin biopsies.
时间窗: Day 1
次要结局
未报告次要终点
